comparemela.com

Latest Breaking News On - Mantle cell lymphoma - Page 7 : comparemela.com

Zanubrutinib as Third-Line and Beyond Therapy for FL

Laurie Sehn, MD, discusses recent data on zanubrutinib, a BTK inhibitor, as third-line and beyond therapy for FL.

Laurie sehnRecent updatesFollicular lymphomaMantle cell lymphomaBeyond therapyThird line therapyThird line and beyondDurable responseFda approvalAugment trialRosewood trialBtk inhibitor

Choosing Bispecific T-cell Engager as Third-line and Beyond Therapy for FL

A panel of experts discuss how to choose bispecific T-cell engagers as third-line and beyond therapy for FL.

Recent updatesFollicular lymphomaMantle cell lymphomaBispecifict cell engagerBeyond therapyThird lineT cell engagerLarge cell lymphomaDosing scheduleStep up dosingSplit dosing

Dr Phillips on the Rationale for the GLOBRYTE Trial in Relapsed/Refractory MCL

Tycel Phillips, MD, discusses the rationale for launching the phase 3 GLOBRYTE trial evaluating glofitamab monotherapy in patients with relapsed/refractory mantle cell lymphoma, highlighting ongoing enrollment efforts.

United kingdomUnited statesSouth koreaTycel phillipsDivision of lymphomaDepartment of hematology hematopoietic cell transplantationHematopoietic cell transplantationMantle cell lymphomaCity of hopeOnclive tv

Dr Danilov on Addressing BTK Inhibitor Resistance in Relapsed/Refractory CLL and MCL

Alexey Danilov, MD, PhD, discusses how further research, including the development of NX-2127, may address unmet needs related to disease progression in patients with chronic lymphocytic leukemia or mantle cell lymphoma.

Alexey danilovDepartment of hematology hematopoietic cell transplantationDivision of leukemiaToni stephenson lymphoma centerHematopoietic cell transplantationCity of hopeMantle cell lymphomaChronic lymphocytic leukemiaOnclive tv

Bispecific T-cell Engagers as Third-line and Beyond Therapy for FL

Matthew Lunning, DO, discusses recent data on bispecific T-cell engagers as third-line and beyond therapy for FL.

Matthew lunningRecent updatesFollicular lymphomaMantle cell lymphomaT cell engagersBeyond therapyBispecifict cell engagersThird line and beyondThird line therapyT cell engagerFollicular lymphoma treatmentFl treatmentStep up dosing

vimarsana © 2020. All Rights Reserved.